Abstract
Objects
We aim to evaluate the characteristics of pediatric patients with neurofibromatosis type 1 (NF1) who developed soft tissue sarcomas (STSs) and central nervous system (CNS) tumors that have been followed up in our center.
Materials and methods
Medical records of children with NF1 were retrospectively analyzed.
Results
There were 78 patients who met at least two diagnostic criteria for NF1. The median age of patients was 10 years (0.5–18), and M/F ratio was 1.3. The prevalance of the optic glioma was 11.5% (n = 9), and one patient with optic glioma also had cystic astrocytoma, one patient had brain stem tumor, and one patient had a CNS tumor (without histopathologic diagnosis). Seven of nine children were ≥7 years old at the time of the diagnosis of optic glioma. Visual impairment developed in four patients, and two of them were treated with radiotherapy solely on the basis of evidence of clinical and radiological progression of the tumors. Four patients developed STSs. Two of them had malignant peripheral nerve sheath tumors (MPNST), and the remaining two had bladder rhabdomyosarcoma. Three of the four patients with STSs died with progressive disease.
Conclusion
The clinical course of malignancy in NF1 is often different from that of similar tumor types in the general population. Careful follow-up in patients with NF1 is required to enable the early diagnosis of malignancies, and the developments of new targeted therapies are needed for improvement of the outcome for patients of this group, especially with MPNST.
Similar content being viewed by others
References
Bader JL, Miller RW (1978) Neurofibromatosis and childhood leukemia. J Pediatr 92:925–929
Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE (2004) Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1. Am J Med Genet A 127A:224–229
Brems H, Beert E, de Ravel T, Legius E (2009) Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10:508–515
Brodeur GM (1994) The NF1 gene in myelopoiesis and childhood myelodysplastic syndromes. N Engl J Med 330:637–639
Brzowski AE, Bazan C III, Mumma JV, Ryan SG (1992) Spontaneous regression of optic glioma in a patient with neurofibromatosis. Neurology 42:679–681
Carli M, Ferrari A, Mattke A, Zanetti I, Casanova M, Bisogno G, Cecchetto G, Alaggio R, De SL, Koscielniak E, Sotti G, Treuner J (2005) Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J Clin Oncol 23:8422–8430
Coffin CM, Cassity J, Viskochil D, Randall RL, Albritton K (2004) Non-neurogenic sarcomas in four children and young adults with neurofibromatosis type 1. Am J Med Genet A 127A:40–43
De RT, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R, Legius E (2003) Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:1288–1292
Distelmaier F, Fahsold R, Reifenberger G, Messing-Juenger M, Schaper J, Schneider DT, Gobel U, Mayatepek E, Rosenbaum T (2007) Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up. Childs Nerv Syst 23:343–347
Doorn PF, Molenaar WM, Buter J, Hoekstra HJ (1995) Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 21:78–82
Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM (1986) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006–2021
Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311–314
Ferrari A, Bisogno G, Carli M (2007) Management of childhood malignant peripheral nerve sheath tumor. Paediatr Drugs 9:239–248
Friedrich RE, Hartmann M, Mautner VF (2007) Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children. Anticancer Res 27:1957–1960
Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51–57
Huttner AJ, Kieran MW, Yao X, Cruz L, Ladner J, Quayle K, Goumnerova LC, Irons MB, Ullrich NJ (2010) Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1. Pediatr Blood Cancer 54:890–896
King AA, Debaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93:388–392
Koszyca B, Moore L, Byard RW (1993) Lethal manifestations of neurofibromatosis type 1 in childhood. Pediatr Pathol 13:573–581
Listernick R, Charrow J (1990) Neurofibromatosis type 1 in childhood. J Pediatr 116:845–853
Listernick R, Charrow J, Greenwald M, Mets M (1994) Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125:63–66
Listernick R, Charrow J, Greenwald MJ, Esterly NB (1989) Optic gliomas in children with neurofibromatosis type 1. J Pediatr 114:788–792
Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189–198
Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J (2004) Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 63:1944–1946
Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 41:143–149
Maria BL, Menkes JH (2006) Neurocutaneous syndromes. In: Menkes JH, Sarnat HB, Maria BL (eds) Chid neurology. Lippincott Williams & Wilkins, Philadelphia, pp 803–828
Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J (1993) Neurofibromatosis type 1 and childhood cancer. Cancer 72:2746–2754
O’Marcaigh AS, Shannon KM (1997) Role of the NF1 gene in leukemogenesis and myeloid growth control. J Pediatr Hematol Oncol 19:551–554
Oguzkan S, Terzi YK, Guler E, Derbent M, Agras PI, Saatci U, Ayter S (2006) Two neurofibromatosis type 1 cases associated with rhabdomyosarcoma of bladder, one with a large deletion in the NF1 gene. Cancer Genet Cytogenet 164:159–163
Onal C, Bayindir C (1999) Gliomatosis cerebri with neurofibromatosis: an autopsy-proven case. Childs Nerv Syst 15:219–221
Perilongo G, Moras P, Carollo C, Battistella A, Clementi M, Laverda A, Murgia A (1999) Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 14:352–356
Piccirilli M, Lenzi J, Delfinis C, Trasimeni G, Salvati M, Raco A (2006) Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature. Childs Nerv Syst 22:1332–1337
Plon SE, Malkin D (2006) Childhood cancer and heredity. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott-Roven, Philedelphia, pp 14–37
Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM (2003) Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 111:777–784
Reich S, Overberg-Schmidt US, Leenen A, Henze G (1999) Neurofibromatosis 1 associated with embryonal rhabdomyosarcoma of the urinary bladder. Pediatr Hematol Oncol 16:263–266
Segal L, Rvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC (2010) Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. J AAPOS 14:155–158
Shearer P, Parham D, Kovnar E, Kun L, Rao B, Lobe T, Pratt C (1994) Neurofibromatosis type I and malignancy: review of 32 pediatric cases treated at a single institution. Med Pediatr Oncol 22:78–83
Sorensen SA, Mulvihill JJ, Nielsen A (1986) Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 314:1010–1015
Sung L, Anderson JR, Arndt C, Raney RB, Meyer WH, Pappo AS (2004) Neurofibromatosis in children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV. J Pediatr 144:666–668
Szudek J, Birch P, Riccardi VM, Evans DG, Friedman JM (2000) Associations of clinical features in neurofibromatosis 1 (NF1). Genet Epidemiol 19:429–439
Uyttebroeck A, Legius E, Brock P, Van de CW, Casaer P, Casteels-Van DM (1995) Consecutive glioblastoma and B cell non-Hodgkin’s lymphoma in a young child with von Recklinghausen’s neurofibromatosis. Med Pediatr Oncol 24:46–49
Conflict of ınterest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cecen, E., Ince, D., Uysal, K.M. et al. Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1. Childs Nerv Syst 27, 1885–1893 (2011). https://doi.org/10.1007/s00381-011-1425-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-011-1425-x